Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter C van den Akker

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|February 25, 2022
In Vitro Models for the Evaluation of Antisense Oligonucleotides in SkinJeroen Bremer, Peter C van den Akker
Methods in Molecular Biology (Clifton, N.J.)|February 25, 2022
In Vivo Models for the Evaluation of Antisense Oligonucleotides in SkinJeroen Bremer, Peter C van den Akker
Biomedicines|September 23, 2022
Revertant Mosaicism in Genodermatoses: Natural Gene Therapy Right before Your EyesPeter C van den Akker, Maria C Bolling, Anna M G Pasmooij
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 10, 2016
Analysis of the functional consequences of targeted exon deletion in COL7A1 reveals prospects for dystrophic epidermolysis bullosa therapyOlivier Bornert, Tobias Kühl, Jeroen Bremer, et al.
Genetic Testing and Molecular Biomarkers|October 10, 2009
Design and validation of a conformation-sensitive capillary electrophoresis system for mutation identification of the COL7A1 gene with automated peak comparisonPeter C van den Akker, Wendy Hettema, Rowdy Meijer, et al.
The British Journal of Dermatology|June 11, 2024
Navigating the diagnostic journey of epidermolysis bullosa: a qualitative study of the lived experiences and needs of parents and patientsEva W H Korte, Rosalie Baardman, Grieteke Pool, et al.
Molecular Therapy. Nucleic Acids|July 1, 2026
Meta-analysis of adverse events in clinical studies with antisense oligonucleotide therapiesCisse Vermeer, Rindert R Venema, Erwin Birnie, et al.
American Journal of Medical Genetics. Part A|December 21, 2022
Uncombable hair syndrome due to maternal uniparental disomy of chromosome 1Hanna Breet, Yvonne J Vos, Trijnie Dijkhuizen, et al.
JAMA Dermatology|July 8, 2016
Association of Epidermolysis Bullosa Simplex With Mottled Pigmentation and EXPH5 MutationsIana Turcan, Anna M G Pasmooij, Peter C Van den Akker, et al.
Archives of Dermatology|October 19, 2011
Natural gene therapy in dystrophic epidermolysis bullosaPeter C van den Akker, Miranda Nijenhuis, Gonnie Meijer, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Methods in Molecular Biology (Clifton, N.J.)|February 25, 2022
In Vitro Models for the Evaluation of Antisense Oligonucleotides in SkinJeroen Bremer, Peter C van den Akker
Methods in Molecular Biology (Clifton, N.J.)|February 25, 2022
In Vivo Models for the Evaluation of Antisense Oligonucleotides in SkinJeroen Bremer, Peter C van den Akker
Biomedicines|September 23, 2022
Revertant Mosaicism in Genodermatoses: Natural Gene Therapy Right before Your EyesPeter C van den Akker, Maria C Bolling, Anna M G Pasmooij
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 10, 2016
Analysis of the functional consequences of targeted exon deletion in COL7A1 reveals prospects for dystrophic epidermolysis bullosa therapyOlivier Bornert, Tobias Kühl, Jeroen Bremer, et al.
Genetic Testing and Molecular Biomarkers|October 10, 2009
Design and validation of a conformation-sensitive capillary electrophoresis system for mutation identification of the COL7A1 gene with automated peak comparisonPeter C van den Akker, Wendy Hettema, Rowdy Meijer, et al.
The British Journal of Dermatology|June 11, 2024
Navigating the diagnostic journey of epidermolysis bullosa: a qualitative study of the lived experiences and needs of parents and patientsEva W H Korte, Rosalie Baardman, Grieteke Pool, et al.
Molecular Therapy. Nucleic Acids|July 1, 2026
Meta-analysis of adverse events in clinical studies with antisense oligonucleotide therapiesCisse Vermeer, Rindert R Venema, Erwin Birnie, et al.
American Journal of Medical Genetics. Part A|December 21, 2022
Uncombable hair syndrome due to maternal uniparental disomy of chromosome 1Hanna Breet, Yvonne J Vos, Trijnie Dijkhuizen, et al.
JAMA Dermatology|July 8, 2016
Association of Epidermolysis Bullosa Simplex With Mottled Pigmentation and EXPH5 MutationsIana Turcan, Anna M G Pasmooij, Peter C Van den Akker, et al.
Archives of Dermatology|October 19, 2011
Natural gene therapy in dystrophic epidermolysis bullosaPeter C van den Akker, Miranda Nijenhuis, Gonnie Meijer, et al.
Pageof 5